ALLIED HEALTHCARE PRODUCTS, INC.: 10-Q filed 2020-11-16
What ALLIED HEALTHCARE PRODUCTS, INC. reported in its quarterly report filed 2020-11-16 (fiscal Q1 2020): 33 published measures, 70 facts as tagged in accession 0001104659-20-125764.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-11-16
- Fiscal period
- fiscal Q1 2020
- Accession
- 0001104659-20-125764 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ALLIED HEALTHCARE PRODUCTS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 19,686,530 | USD | |
| At 2020-06-30 | 19,672,359 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 8,725,815 | USD | |
| At 2020-06-30 | 8,878,667 | USD | |
| At 2019-09-30 | 11,277,022 | USD | |
| At 2019-06-30 | 11,890,352 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 5,876 | USD | |
| At 2020-06-30 | 2,600,083 | USD | |
| At 2019-09-30 | 302,436 | USD | |
| At 2019-06-30 | 195,454 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -153,381 | USD | 92 |
| 2019-07-01 to 2019-09-30 | -614,123 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -3,631,429 | USD | 92 |
| 2019-07-01 to 2019-09-30 | -717,017 | USD | 92 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 167,163 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 26,005 | USD | 92 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 10,189,548 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 7,975,637 | USD | 92 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 1,204,385 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 850,004 | USD | 92 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -167,163 | USD | 92 |
| 2019-07-01 to 2019-09-30 | -26,005 | USD | 92 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 4,013,537 | shares | 92 |
| 2019-07-01 to 2019-09-30 | 4,013,537 | shares | 92 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 0 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 0 | USD | 92 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 4,142,322 | USD | |
| At 2020-06-30 | 4,139,693 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 529 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 793 | USD | 92 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -135,287 | USD | 92 |
| 2019-07-01 to 2019-09-30 | -607,393 | USD | 92 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 14,887,177 | USD | |
| At 2020-06-30 | 14,874,573 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 18,250 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 6,752 | USD | 92 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 9,860,598 | USD | |
| At 2020-06-30 | 8,925,411 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 3,484,335 | USD | |
| At 2020-06-30 | 2,940,006 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 3,277,152 | USD | |
| At 2020-06-30 | 3,103,819 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 11,255,918 | USD | |
| At 2020-06-30 | 8,928,688 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 1,873,811 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 1,259,694 | USD | 92 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 2,009,098 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 1,867,087 | USD | 92 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 4,013,537 | shares | |
| At 2020-06-30 | 4,013,537 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | -18,839,797 | USD | |
| At 2020-06-30 | -18,686,416 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 16,264 | USD | |
| At 2020-06-30 | 17,326 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 2,478,945 | USD | |
| At 2020-06-30 | 2,106,131 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -153,381 | USD | 92 |
| 2019-07-01 to 2019-09-30 | -614,123 | USD | 92 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 164,534 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 180,785 | USD | 92 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 0 | USD | 92 |
| 2019-07-01 to 2019-09-30 | -10 | USD | 92 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -18,094 | USD | 92 |
| 2019-07-01 to 2019-09-30 | -6,730 | USD | 92 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 172,703 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 17,136 | USD | 92 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 2,327,230 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 19,951 | USD | 92 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 544,329 | USD | 92 |
| 2019-07-01 to 2019-09-30 | 100,449 | USD | 92 |
Inspect the source
- Entity
- ALLIED HEALTHCARE PRODUCTS, INC. / CIK 0000874710
- Captured
- SEC response SHA-256
f694204a453d7f425517aaaf1b9247d581a7c239a0c125906f119959cddf46dc
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000874710.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))